The CMOP regimen demonstrates a favorable PK profile, a manageable safety profile, and encouraging preliminary antitumor activity.
Combination of mitoxantrone hydrochloride liposome with cyclophosphamide, vincristine, and prednisone for patients with treatment‐naive peripheral T‐cell lymphoma: A multicenter, open‐label, single‐arm, phase 1b trial
Yan Gao·Huiqiang Huang·Yufu Li·Lihong Liu·Hui Zhou·Xin Wang·Xuanye Zhang·Xiaojing Yan·Ming Jiang·Liling Zhang